Wie hoch ist der Preis für Aspire Biopharma Holdings, Inc. (ASBP)

Preis für Aspire Biopharma Holdings, Inc. (ASBP) ist $7.28

Wie hoch ist die Marktkapitalisierung für Aspire Biopharma Holdings, Inc. (ASBP)

Marktkapitalisierung für Aspire Biopharma Holdings, Inc. (ASBP) ist $839.91K

Aspire Biopharma Holdings, Inc. (ASBP) Umsatz

Aspire Biopharma Holdings, Inc. is an emerging pharmaceutical enterprise dedicated to pioneering and commercializing innovative sublingual drug delivery systems within the United States. Its flagship product, Instaprin, is an advanced sublingual aspirin formulation known for being soluble, pH neutral, and rapidly absorbed, making it effective for both cardiovascular emergencies and general pain management. The company is diligently developing a diverse pipeline of orally dissolving formulations. This includes a melatonin-based sleep aid, essential vitamins (D, E, and K), testosterone, and semaglutide. Furthermore, Aspire Biopharma is extending its sublingual development efforts to various therapeutic areas, such as anti-nausea treatments, antipsychotic medications, erectile dysfunction drugs, and seizure control therapies, among others. They are also exploring caffeine products, including a formulation for a single-dose sublingual pre-workout supplement. Established in 2021, the firm's main operational base is situated in Estero, Florida.

Jahr	Umsatz	ändert
Nicht genügend Daten für die angegebenen Daten.

Jahr

Umsatz

ändert

Nicht genügend Daten für die angegebenen Daten.

Unternehmen	Umsatz	Umsatzunterschied	Land
Vertex Pharmaceuticals Incorporated VRTX.US	$12.62B	-	US
Argenx SE ARGX.US	$6.02B	-	NL
Lonza Group AG LONN.SW	-	-	CH
Samsung Biologics Co.,Ltd. 207940.KS	-	-	KR
UCB S.A. UCB.BR	$10.11B	-	BE

Unternehmen

Umsatz

Umsatzunterschied

Land